Showing 5,803 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

CytoDyn announces submission of revised HIV clinical trial protocol to FDA

Editor's pick
CytoDyn press release
6 February 2024
PrEP science

Kidney Function Not Improved in Patients Who Switch to TAF-Based PrEP

Editor's pick
Infectious Disease Advisor
6 February 2024
Ageing & HIV

Too many older people with HIV taking medicines they may not need

News
2 February 2024
Starting treatment

Starting HIV Treatment Sooner Leads to Better Immune Recovery

Editor's pick
POZ
1 February 2024
Injectable & long-acting HIV treatment

Cabotegravir levels lower than trials in real-world study, but no increase in viral rebound

News
1 February 2024
HIV treatment

Dolutegravir-based triple therapy effectively suppresses HIV-2 viral load in small study

News
30 January 2024
Weight gain & lipodystrophy

FDA Denies Approval of F8 Formulation of Tesamorelin for HIV-Related Lipodystrophy

Editor's pick
Infectious Disease Advisor
29 January 2024
New & experimental HIV treatments

Lenacapavir May Be Beneficial for Individuals Infected With HIV-2

Editor's pick
Infectious Disease Advisor
29 January 2024
The search for a cure

HIV: early treatment, one key to remission

Editor's pick
ANRS
23 January 2024
Undetectable viral load & treatment as prevention

With Immediate Treatment of HIV, Semen Viral Load Drops Rapidly, Reports Small Study

Editor's pick
TheBodyPro
18 January 2024
Retention & linkage to care

Multiple strategies needed to reduce disengagement from HIV care in Uganda

News
17 January 2024
People with limited treatment options

People with HIV still running out of treatment options – not always because of resistance

News
16 January 2024
Sexually transmitted infections prevention

DoxyPEP did not reduce STIs among women, probably due to low adherence

News
15 January 2024
How HIV works

Higher viral load during HIV infection can shape viral evolution

Editor's pick
EurekAlert!
10 January 2024
New & experimental HIV treatments

Calibr announces license agreement with Gilead to develop a long-acting HIV antiviral agent for treatment in combination with lenacapavir

Editor's pick
EurekAlert!
8 January 2024
PrEP science

Resistance Mutation Associated With PrEP Use in People Newly Diagnosed With HIV in New York City

Editor's pick
TheBodyPro
5 January 2024
PrEP science

Oral PrEP can work just as well for women as men, modelling studies conclude

News
29 December 2023
PrEP science

On-Demand Versus Daily PrEP May Mitigate TDF’s Effect on Kidneys, Reports French Study

Editor's pick
TheBodyPro
28 December 2023
Resistance

History of PrEP Use Linked to M184I/V Mutation at HIV Diagnosis

Editor's pick
Infectious Disease Advisor
22 December 2023
Exercise

Exercise Linked to Less Belly Fat in People With HIV

Editor's pick
POZ
22 December 2023
Neurological & cognitive problems

HIV drugs might help prevent multiple sclerosis, large new study suggests

Editor's pick
The Conversation
22 December 2023
Resistance

New HIV drugs should be classed as inferior if they carry a higher risk of resistance

News
22 December 2023
Cancer

New evidence on cervical cancer screening and treatment for women living with HIV

Editor's pick
World Health Organization
20 December 2023
New & experimental HIV treatments

Trogarzo [Ibalizumab] Label Updated With 90-Second IV Push Loading Dose

Editor's pick
Infectious Disease Advisor
20 December 2023